CAS: 143322-57-0; (R)-5-Bromo-3-[(1-Methyl-2-Pyrrolidinyl)Methyl]-1H-Indole

该化合物是一种化学化合物,其特性是其单极核心,这是一种双环结构,由苯环组成,与一个发酵环相连.在不荷尔的5个位置上存在一个溴原子,会增强其反应性并影响其生物活动.该化合物还具有一个侧链,包括一个含有5个成分的含氮的乙基环.2R-1-甲基-2-丙基氨基组表明气态,表明该分子可能以不同立体异构体形式存在,可能会影响其药用特性.该化合物可能呈现出各种生物活动,使其对医药化学和药物开发感兴趣.其具体的相互作用和行动机制将取决于其结构特征和它所涉及的生物目标.与许多含有含有含氮的衍生物一样,它可能被用于...

结构式图片

欧盟法规

统一分类与标签REACH注册ECHA物质工作场所安全标识要求食品接触材料-禁用CMR物质ECHA物质C&L通报化妆品禁用物质清单REACH预注册废弃物危险特性清单

上下游产品

CAS号143322-56-9 R-3-(N-苄氧基羰基吡咯烷... | CAS号1353991-68-0 (R)-2-(5-bromo-... | CAS号6404-31-5 N-CBZ-D-脯氨酸 | CAS号61350-62-7 (R)-N-[(phenylm... | CAS号105370-80-7 (R)-pyrrolidine... | CAS号1353991-67-9 (R)-2-chlor°Car... | CAS号205369-12-6 (R)-N-乙酰基-5-溴-3... | CAS号3112-85-4 甲基苯基砜 | CAS号143322-58-1 依来曲普坦 | CAS号143322-55-8 (R)-3-((1-甲基吡咯烷... | CAS号177834-92-3 依来曲普坦氢溴酸盐 | CAS号180637-89-2 (R)-3-[(1-甲基-2-...

合成工艺路线路线简述

  • 合成目标产物 (R)-5-Bromo-3-((1-Methylpyrrolidin-2-yl)Methyl)-1H-Indole 主要起始原料 1H-Indole, 5-Bromo-3-[[(2R)-1-Methyl-2-Pyrrolidinyl]Methyl]-, Ethanedioate (1:1)
  • (文献来源)合成步骤主要原料 1H-Indole, 5-Bromo-3-[[(2R)-1-Methyl-2-Pyrrolidinyl]Methyl]-, Ethanedioate (1:1)
(R)-2-(5-溴-1H-吲哚-3-羰基)吡咯烷-1-羧酸苯酯置于红铝,Sodium Hydroxide体系中,用 甲苯,水 用作溶剂,化学反应生成(R)-5-溴-3-(1-甲基-2-吡咯烷基甲基)-1H-吲哚
参考文献: Process For The Preparation Of 5-Substsituted Indole Derivative[fr] Procédé Pour La Préparation De Dérivé D'Indole Substitué En Position 5
标题: Process For The Preparation Of 5-Substsituted Indole Derivative[fr] Procédé Pour La Préparation De Dérivé D'Indole Substitué En Position 5

海关参考信息

专利信息


专利号:US-8426612-B2
优先权日:2009-04-22
标 题:Synthesis of 3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5[2-(phenylsulfonyl)ethyl]-1H-indole
发明人:SERAFINI SIRO; CASTELLIN ANDREA; DAL SANTO CLAUDIO
权利人:SERAFINI SIRO; CASTELLIN ANDREA; DAL SANTO CLAUDIO; ITALIANA SINT SPA
摘要:The present invention refers to the synthesis of 3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1H-indole, a drug known by the name Eletriptan, or of its salts. In particular, the present invention regards a process for the synthesis of Eletriptan or of its salt, comprising the following steps: a) Salifying the intermediate of Formula (6), using a dicarboxylic acid to obtain a derived salt; b) Optionally, purifying said raw salt obtained according to step a) by solvent crystallization to obtain a purified salt of the intermediate of Formula (6); c) Converting said salt of the intermediate of formula (6) according to step a) or said purified salt according to step b) into an intermediate of formula (10); d) Converting the intermediate of Formula (10) into Eletriptan or its salt.

专利号:WO-2012004811-A8
优先权日:2010-07-06
标题:Process for the preparation of 5-substsituted indole derivative
发明人:BHIRUD SHEKHAR BHASKAR; JOHAR PERMINDER SINGH; SHARMA EKTA; PRAJAPATY RAMKARAN; GUPTA CHANDAN KUMAR
权利人:IND SWIFT LAB LTD; BHIRUD SHEKHAR BHASKAR; JOHAR PERMINDER SINGH; SHARMA EKTA; PRAJAPATY RAMKARAN; GUPTA CHANDAN KUMAR
摘要:The present invention relates to an improved and industrially advantageous process for preparation of eletriptan of formula I, or pharmaceutically acceptable salts thereof from bromo indole intermediate of formula II, through isolation of N-acetylated bromo indole intermediate of formula III, to elude carrying forward of impurities to next stage. The present invention relates to process for the preparation of 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indol of formula II, a key intermediate for the synthesis of eletriptan or pharmaceutically acceptable salts thereof, through novel keto carbamate intermediate. The present invention also relates to novel process for the preparation of α-form of eletriptan hydrobromide.

专利号:WO-2010121673-A1
优先权日:2009-04-22
标 题 :Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole

专利号:JP-2012524736-A
优先权日:2009-04-22
标 题 :Synthesis of 3-{[(2R) -1-methylpyrrolidin-2-yl] methyl} -5- [2- (phenylsulfonyl) ethyl] 1H-indole

专利号:US-2011166364-A1
优先权日:2009-04-22
标 题 :Synthesis of 3--5-[2-(phenylsulfonyl)ethyl]-1h-indole

专利号:EP-2421853-B1
优先权日:2009-04-22
标 题:Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole
威智医药股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.viwit.com
企业联系电话:0632-2980981;15063270987👤
📞威智医药股份有限公司 ⚠️参考联系方式
联系人:翁经理
电话:0632-2980981;15063270987
手机:15063270987
传真:QQ2730058784
邮箱:service.china3@viwit.com
通信地址: 山东省滕州市生物医药产业基地威智大道88号
邮编: 277514
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:山东省滕州市生物医药产业基地威智大道88号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知